PranaX Corporation Secures $17 Million to Advance Exosome Technology in Regenerative Medicine PranaX Corporation has successfully closed a $17 million Series A financing round to enhance its research in regenerative biologics, focusing on exosomes.

PranaX Corporation Secures $17 Million to Advance Exosome Technology in Regenerative Medicine #United_States #Houston #regenerative_medicine #exosome_technology #PranaX

PranaX's Exosome Technology Gains Attention in Nature Communications Journal A recent publication in Nature Communications highlights PranaX's licensed exosome technology, marking a significant step in regenerative medicine advancements.

PranaX's Exosome Technology Gains Attention in Nature Communications Journal #USA #Houston #regenerative_medicine #exosome_technology #PranaX

Sparkling Sciences Exhibits at COSME Week Osaka with a Focus on Anti-Aging Innovations Sparkling Sciences will participate in COSME Week Osaka 2025, showcasing advanced exosome technology for skincare and pet care, enhancing anti-aging research.

Sparkling Sciences Exhibits at COSME Week Osaka with a Focus on Anti-Aging Innovations #Japan #Osaka #Anti-Aging #exosome_technology #Sparkling_Sciences

PranaX Corporation Welcomes Phillip Maderia as New CEO to Propel Exosome Innovations PranaX Corporation has appointed Phillip Maderia as CEO. With a strong background in exosome technology, he aims to enhance health through innovative solutions.

PranaX Corporation Welcomes Phillip Maderia as New CEO to Propel Exosome Innovations #USA #Houston #exosome_technology #PranaX #Phillip_Maderia

Taiwan's CMU Healthcare System and Randy Schekman Lead Advances in Exosome Technology The International Forum on Extracellular Vesicles hosted by CMU Healthcare System saw Nobel Laureate Randy Schekman discussing exosome technology in Taiwan.

Taiwan's CMU Healthcare System and Randy Schekman Lead Advances in Exosome Technology #Taiwan #exosome_technology #Taichung #Randy_Schekman

BrainStorm Cell Therapeutics Expands Its Patent Portfolio for Exosome Technology BrainStorm Cell Therapeutics has been granted a Notice of Allowance for a U.S. patent covering its groundbreaking exosome technology, enhancing its intellectual property.

BrainStorm Cell Therapeutics Expands Its Patent Portfolio for Exosome Technology #USA #New_York #BrainStorm #exosome_technology #BCLI